clofarabine has been researched along with Local Neoplasm Recurrence in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (21.74) | 29.6817 |
| 2010's | 13 (56.52) | 24.3611 |
| 2020's | 5 (21.74) | 2.80 |
| Authors | Studies |
|---|---|
| Baer, MR; Blackford, AL; Carraway, HE; Dezern, A; Ghosh, N; Gojo, I; Gore, L; Gore, SD; Greer, J; Karp, JE; Lee, MJ; Lee, S; Levis, MJ; Piekarz, R; Pratz, KW; Sawalha, Y; Smith, BD; Tomita, Y; Trepel, JB; Yuno, A | 1 |
| Ahmed, S; Alousi, A; Andersson, BS; Bashir, Q; Bassett, R; Champlin, RE; Chen, J; Ciurea, S; Cool, R; Gulbis, A; Hosing, C; Kawedia, J; Kebriaei, P; Kornblau, S; Ma, J; Myers, A; Nieto, Y; Oran, B; Parmar, S; Popat, UR; Rezvani, K; Shah, N; Shpall, E; Thall, PF; Valdez, BC | 1 |
| An, HY; Choi, HJ; Choi, JY; Hong, KT; Kang, HJ; Kim, BK; Shin, HY | 1 |
| Cloos, J; Hanekamp, D; Janssen, JJWM; Ngai, LL; Ossenkoppele, GJ; van de Loosdrecht, A | 1 |
| Cho, B; Cho, H; Choi, JY; Chung, NG; Hahn, SM; Han, JW; Hong, CR; Hong, KT; Im, HJ; Jang, PS; Jeon, IS; Kang, HJ; Kim, H; Kim, S; Koh, KN; Koo, HH; Kook, H; Lee, JW; Lim, YT; Lyu, CJ; Seo, JJ; Shin, HY; Yang, EJ; Yoo, KH | 1 |
| Borthakur, G; Brandt, M; Cortes, JE; Daver, NG; DiNardo, CD; Estrov, Z; Gandhi, V; Garcia-Manero, G; Huang, X; Jabbour, E; Jain, N; Kadia, TM; Kantarjian, H; Konopleva, M; O'Brien, SM; Pemmaraju, N; Plunkett, W; Ravandi, F; Sasaki, K; Short, NJ; Wierda, WG; Xiao, L | 1 |
| Isaac McGraw, B; Savaşan, S; Sweeney, C | 1 |
| Altuntaş, F; Ayyildiz, MO; Bekdemir, F; Çakar, MK; Dal, MS; Dogu, MH; Hacioglu, SK; Ilkkiliç, K; Karakus, A; Kaya, AH; Korkmaz, S; Merdin, A; Tekgündüz, E | 1 |
| Agarwal, R; Artz, A; Godley, LA; Gurbuxani, S; Kunnavakkam, R; Larson, RA; Le Beau, MM; Liu, H; Locke, F; Odenike, O; Sipkins, D; Stock, W; Thirman, MJ; van Besien, K; White, C | 1 |
| Azzarà, A; Benedetti, E; Buda, G; Caracciolo, F; Carulli, G; Fontanelli, G; Galimberti, S; Orciuolo, E; Petrini, M; Rocco, M | 1 |
| Burke, MJ; Gorman, MF; Gossai, N; Karras, NA; Patel, NJ; Verneris, MR | 1 |
| Patrick, K; Vora, A | 1 |
| Baruchel, A; Bertrand, Y; Brethon, B; Cave, H; Galambrun, C; Gandemer, V; Leverger, G; Nelken, B; Plat, G; Rohrlich, P; Schmitt, C; Thomas, C; Vérité, C | 1 |
| Aoki, Y; Imai, K; Ishiwata, Y; Kajiwara, M; Miyawaki, R; Mizutani, S; Morio, T; Takagi, M; Tomizawa, D; Yasuhara, M | 1 |
| Ferrara, F; Musto, P | 1 |
| Abichandani, R; Arellano, M; Claxton, D; Craig, M; Douer, D; Eckert, S; Erba, HP; Faderl, S; Gabrilove, J; Kantarjian, HM; Kovascovics, T; Lyons, RM; Maris, M; Petersdorf, S; Shami, PJ; Yeager, AM | 1 |
| Abonour, R; Baute, J; Cox, E; Farag, SS; Jones, DR; Kane, K; Nelson, RP; Robertson, MJ; Schwartz, JE; Secrest, A; Srivastava, S; Sullivan, C; Wood, LL | 1 |
| Agura, E; Berryman, RB; Cooper, B; Fay, J; Holmes, H; Li, S; Maisel, C; Saracino, G; Tadic-Ovcina, M; Vance, E | 1 |
| Adlard, K; Alonzo, TA; Cooper, TM; Gamis, AS; Gerbing, R; Perentesis, J; Raetz, E; Razzouk, BI; Whitlock, JA | 1 |
| Corey, SJ; Elopre, M; Goldman, FD; Robinson, LJ; Rumelhart, S; Rytting, ME; Weitman, S | 1 |
| DiPersio, JF; Ruddell, A; Tomasson, MH; Uy, GL; Vij, R | 1 |
| Balakrishnan, K; Briel, J; Carraway, H; Gandhi, V; Gore, SD; Greer, J; Karp, JE; Levis, MJ; McDevitt, MA; Ricklis, RM; Smith, BD | 1 |
| Johnston, DL; Mandel, KM | 1 |
2 review(s) available for clofarabine and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Update on biology and treatment of T-cell acute lymphoblastic leukaemia.
Topics: Adenine Nucleotides; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Child; Child, Preschool; Clofarabine; Humans; Infant; Neoplasm Recurrence, Local; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Treatment Outcome | 2015 |
Clofarabine: in search of combinations for the treatment of patients with high-risk acute myeloid leukemia.
Topics: Adenine Nucleotides; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Clinical Trials as Topic; Clofarabine; Humans; Leukemia, Myeloid, Acute; Neoplasm Recurrence, Local | 2008 |
11 trial(s) available for clofarabine and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Phase 1 study of the histone deacetylase inhibitor entinostat plus clofarabine for poor-risk Philadelphia chromosome-negative (newly diagnosed older adults or adults with relapsed refractory disease) acute lymphoblastic leukemia or biphenotypic leukemia.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cell Lineage; Clofarabine; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Histone Deacetylase Inhibitors; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Pyridines; Salvage Therapy; Young Adult | 2021 |
A randomized phase III study of pretransplant conditioning for AML/MDS with fludarabine and once daily IV busulfan ± clofarabine in allogeneic stem cell transplantation.
Topics: Bayes Theorem; Busulfan; Clofarabine; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Transplantation Conditioning; Vidarabine | 2022 |
Early assessment of clofarabine effectiveness based on measurable residual disease, including AML stem cells.
Topics: Antimetabolites, Antineoplastic; Clofarabine; Humans; Leukemia, Myeloid, Acute; Neoplasm Recurrence, Local; Neoplasm, Residual; Neoplastic Stem Cells; Treatment Outcome | 2021 |
A phase I/II randomized trial of clofarabine or fludarabine added to idarubicin and cytarabine for adults with relapsed or refractory acute myeloid leukemia.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Clofarabine; Cytarabine; Drug Resistance, Neoplasm; Humans; Idarubicin; Leukemia, Myeloid, Acute; Middle Aged; Neoplasm Recurrence, Local; Progression-Free Survival; Remission Induction; Survival Rate; Treatment Outcome; Vidarabine; Young Adult | 2018 |
A novel clofarabine bridge strategy facilitates allogeneic transplantation in patients with relapsed/refractory leukemia and high-risk myelodysplastic syndromes.
Topics: Adenine Nucleotides; Adult; Aged; Antimetabolites, Antineoplastic; Arabinonucleosides; Clofarabine; Hematopoietic Stem Cell Transplantation; Humans; Middle Aged; Myelodysplastic Syndromes; Neoplasm Recurrence, Local; Prospective Studies; Retrospective Studies; Transplantation Conditioning; Transplantation, Homologous; Young Adult | 2013 |
A Phase I Study of Clofarabine With Multiagent Chemotherapy in Childhood High Risk Relapse of Acute Lymphoblastic Leukemia (VANDEVOL Study of the French SFCE Acute Leukemia Committee).
Topics: Adenine Nucleotides; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Asparaginase; Child; Child, Preschool; Clofarabine; Dexamethasone; Dose-Response Relationship, Drug; Etoposide; Female; Humans; Male; Maximum Tolerated Dose; Mitoxantrone; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Salvage Therapy; Young Adult | 2016 |
Phase II study of clofarabine monotherapy in previously untreated older adults with acute myeloid leukemia and unfavorable prognostic factors.
Topics: Adenine Nucleotides; Aged; Aged, 80 and over; Antineoplastic Agents; Arabinonucleosides; Clofarabine; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Prospective Studies; Remission Induction; Survival Rate; Treatment Outcome | 2010 |
Phase I trial and pharmacokinetic study of high-dose clofarabine and busulfan and allogeneic stem cell transplantation in adults with high-risk and refractory acute leukemia.
Topics: Adenine Nucleotides; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Busulfan; Clofarabine; Combined Modality Therapy; Female; Graft vs Host Disease; Humans; Leukemia, Myeloid, Acute; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk Factors; Stem Cell Transplantation; Survival Rate; Tissue Distribution; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Young Adult | 2011 |
Report of a phase II study of clofarabine and cytarabine in de novo and relapsed and refractory AML patients and in selected elderly patients at high risk for anthracycline toxicity.
Topics: Adenine Nucleotides; Adult; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Clofarabine; Cytarabine; Disease-Free Survival; Drug Administration Schedule; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Middle Aged; Neoplasm Recurrence, Local; Patient Selection; Recurrence; Remission Induction; Survival Analysis; Treatment Outcome | 2011 |
Phase I/II trial of clofarabine and cytarabine in children with relapsed/refractory acute lymphoblastic leukemia (AAML0523): a report from the Children's Oncology Group.
Topics: Adenine Nucleotides; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Child; Child, Preschool; Clofarabine; Cytarabine; Dose-Response Relationship, Drug; Female; Humans; Infant; Kaplan-Meier Estimate; Male; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Young Adult | 2013 |
A phase 1 clinical-laboratory study of clofarabine followed by cyclophosphamide for adults with refractory acute leukemias.
Topics: Acute Disease; Adenine Nucleotides; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Arabinonucleosides; Clofarabine; Cyclophosphamide; DNA Damage; DNA Repair; Female; Histones; Humans; Leukemia, Myeloid; Male; Middle Aged; Neoplasm Recurrence, Local; Phosphorylation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome | 2007 |
10 other study(ies) available for clofarabine and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Combination Therapy With Chemotherapy, Donor Lymphocyte Infusion With Concurrent Blinatumomab in Relapsed/Refractory Acute Precursor B-Lymphoblastic Leukemia.
Topics: Antibodies, Bispecific; Antineoplastic Combined Chemotherapy Protocols; Blood Donors; Clofarabine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Drug Resistance, Neoplasm; Etoposide; Humans; Infant; Lymphocyte Transfusion; Male; Neoplasm Recurrence, Local; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Retrospective Studies | 2021 |
Effectiveness and Safety of Clofarabine Monotherapy or Combination Treatment in Relapsed/Refractory Childhood Acute Lymphoblastic Leukemia: A Pragmatic, Non-interventional Study in Korea.
Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Child; Child, Preschool; Clofarabine; Combined Modality Therapy; Drug Resistance, Neoplasm; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Male; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Prospective Studies; Republic of Korea; Salvage Therapy; Survival Rate; Young Adult | 2021 |
Recurrent urinary tract infections and low secretory IgA following CD19-directed CAR T-cell therapy for relapsed acute lymphoblastic leukemia.
Topics: Antigens, CD19; Antimetabolites, Antineoplastic; B-Lymphocytes; Bacteriuria; Child; Clofarabine; Cytarabine; Escherichia coli; Escherichia coli Infections; Female; Humans; Immunoglobulin A, Secretory; Immunoglobulin G; Immunoglobulin M; Immunotherapy, Adoptive; Lymphocyte Count; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proteus Infections; Proteus mirabilis; Urinary Tract Infections | 2018 |
Efficacy of CLARA in recurrent/refractory acute myeloid leukaemia patients unresponsive to FLAG chemotherapy.
Topics: Adenine Nucleotides; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Clofarabine; Cytarabine; Drug Resistance, Neoplasm; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Salvage Therapy; Vidarabine; Young Adult | 2018 |
Sorafenib as monotherapy or in association with cytarabine and clofarabine for the treatment of relapsed/refractory FLT3 ITD-positive advanced acute myeloid leukemia.
Topics: Adenine Nucleotides; Adult; Arabinonucleosides; Clofarabine; Cytarabine; Female; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Mutation; Neoplasm Recurrence, Local; Niacinamide; Phenylurea Compounds; Sorafenib; Tandem Repeat Sequences; Young Adult | 2014 |
A clofarabine-based bridging regimen in patients with relapsed ALL and persistent minimal residual disease (MRD).
Topics: Adenine Nucleotides; Adolescent; Antimetabolites, Antineoplastic; Arabinonucleosides; Child; Child, Preschool; Clofarabine; Cyclophosphamide; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Infant; Neoplasm Recurrence, Local; Neoplasm, Residual; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Probability; Remission Induction; Time Factors; Treatment Outcome; Young Adult | 2014 |
Haploidentical Bone Marrow Transplantation With Clofarabine and Busulfan Conditioning for a Child With Multiple Recurrent Acute Lymphoblastic Leukemia.
Topics: Adenine Nucleotides; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Arabinonucleosides; Bone Marrow Transplantation; Busulfan; Child, Preschool; Clofarabine; Humans; Male; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Transplantation Conditioning; Transplantation, Homologous | 2016 |
Complete remission following clofarabine treatment in refractory juvenile myelomonocytic leukemia.
Topics: Adenine Nucleotides; Antineoplastic Agents; Arabinonucleosides; Bone Marrow Transplantation; Child; Clofarabine; Drug Resistance, Neoplasm; Humans; Leukemia, Myelomonocytic, Chronic; Male; Neoplasm Recurrence, Local; Remission Induction; Treatment Outcome | 2005 |
The activity and toxicity of low dose clofarabine against relapsed or refractory myeloma.
Topics: Adenine Nucleotides; Adult; Aged; Arabinonucleosides; Clofarabine; Female; Humans; Male; Middle Aged; Multiple Myeloma; Neoplasm Recurrence, Local; Neutropenia | 2006 |
Fatal skin and liver toxicity in a patient treated with clofarabine.
Topics: Adenine Nucleotides; Antineoplastic Agents; Arabinonucleosides; Chemical and Drug Induced Liver Injury; Child; Clofarabine; Fatal Outcome; Female; Humans; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Skin Diseases | 2008 |